GANX
Gain Therapeutics, Inc.
+0.05 (+2.91%)1.77USD151K成交股數77.2M市值–本益比(近四季)1114.5股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 105K-19% | 85K+53% | 115K | 106K | 130K | 55K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.1M | 2.8M | 2.8M | 2.8M | 2.3M | 1.2M | 2.6M | 4.4M | 2.5M | 2.4M | 4.0M | 2.8M |
| 銷售管理費用 | 2.5M | 2.6M | 1.9M | 2.3M | 2.1M | 2.1M | 1.8M | 3.7M | 1.9M | 2.5M | 3.7M | 2.5M |
| 營業利益 | −4.7M+7% | −5.4M+61% | −4.8M+7% | −5.1M-38% | −4.4M-0% | −3.3M-32% | −4.5M-42% | −8.2M+56% | −4.4M | −4.9M | −7.7M | −5.2M |
| 營業利益率 | – | – | – | – | – | – | -4,230.3% | -9,680.3% | -3,796.7% | -4,608.5% | -5,950.3% | -9,477.7% |
| 稅後淨利 | −4.7M+3% | −5.6M+49% | −5.3M+18% | −5.8M-29% | −4.5M+13% | −3.8M-20% | −4.5M-42% | −8.1M+59% | −4.0M | −4.7M | −7.7M | −5.1M |
| 淨利率 | – | – | – | – | – | – | -4,255.7% | -9,633.2% | -3,481.4% | -4,451.2% | -5,917.1% | -9,310.1% |
| 稀釋 EPS | -0.11-31% | -0.13+63% | -0.15-12% | -0.19-55% | -0.16-27% | -0.08-78% | -0.17-73% | -0.42-2% | -0.22 | -0.37 | -0.62 | -0.43 |
| 稀釋股數 | 42.9M | 42.2M | 35.0M | 30.3M | 28.7M | 22.9M | 26.5M | 19.2M | 18.0M | 12.7M | 12.4M | 11.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 13.1M | 16.5M | 8.8M | 6.7M | 9.1M | 10.4M | 12.0M | 16.9M | 10.6M | 4.3M | 6.3M | 6.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 15.4M | 18.7M | 11.0M | 9.8M | 11.6M | 12.1M | 14.4M | 19.2M | 14.6M | 14.1M | 18.3M | 21.3M |
| 有息負債 | 220K | 273K | 299K | 325K | 314K | 328K | 376K | 375K | 397K | 435K | 467K | 478K |
| 總負債 | 4.1M | 4.7M | 5.1M | 6.1M | 5.8M | 4.8M | 5.5M | 7.4M | 5.9M | 6.8M | 7.2M | 6.2M |
| 股東權益 | 11.3M | 14.0M | 5.9M | 3.7M | 5.8M | 7.3M | 8.9M | 11.8M | 8.6M | 7.3M | 11.1M | 15.1M |
| 負債比 | 26.8% | 25.3% | 46.1% | 62.4% | 50.3% | 39.5% | 38.0% | 38.6% | 40.7% | 48.0% | 39.3% | 29.0% |
| 淨現金(現金 − 有息負債) | 12.9M | 16.3M | 8.5M | 6.4M | 8.8M | 10.1M | 11.7M | 16.6M | 10.2M | 3.8M | 5.9M | 5.5M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.7M | – | – | −3.8M+7% | – | – | – | −3.6M | – | – | −4.2M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 11K |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −4.2M |
| 折舊攤銷 | – | 21K | – | – | 21K | – | – | – | 21K | – | – | 19K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | -7,663.0% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −20.2M | –% | -0.61 | – |
| FY2024 | – | – | −20.4M | –% | -0.89 | −18.9M |
| FY2023 | 55K | -58.4% | −22.3M | -40,354.3% | -1.71 | −18.9M |
| FY2022 | 133K | -1.0% | −17.6M | -13,262.0% | -1.48 | −14.8M |
| FY2021 | 134K | +363.7% | −13.9M | -10,371.7% | -1.37 | −12.5M |
| FY2020 | 29K | – | −3.6M | -12,387.7% | -1.33 | −3.3M |